Drug application
DOPAR (LEVODOPA)
Drugs@FDA NDA 016913 · SHIRE
Key facts
| Drug name | DOPAR |
|---|---|
| Active ingredients | LEVODOPA |
| Application type | NDA |
| Application number | 016913 |
| Company | SHIRE |
| Dosage forms | CAPSULE, ORAL |
| Strength | 250MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Jun 4, 1970 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.